Freyr Completed the MHRA Registration Process for 700 Medical Devices
New Jersey, February 04, 2022 Freyr is pleased to announce the successful MHRA registration process for 700 Medical Devices for an American medical device manufacturer domiciled in the UK and develops cardiac surgery and neuromodulation devices. Freyr offers a comprehensive range of Regulatory services for global compliance requirements for large, medium, and small Medical
- (1888PressRelease) February 15, 2022 - Freyr is pleased to announce the successful MHRA registration process for 700 Medical Devices for an American medical device manufacturer domiciled in the UK and develops cardiac surgery and neuromodulation devices.
Freyr offers a comprehensive range of Regulatory services for global compliance requirements for large, medium, and small Medical Device and In Vitro Diagnostic Device (IVD) companies. With expertise in governing the development, performance testing and validation, manufacturing, labelling, and registration, as well as distribution of Medical Devices and In Vitro Diagnostic Devices (IVD) worldwide, Freyr has already proven to be a preferred partner for 170+ Medical Device companies, including 3 Forbes Global Top 5 Device companies.
It gives us immense pleasure that we have successfully assisted our customer to complete the MHRA registration process for more than 700 devices. It is a proud moment for Freyr, and we would bestow the entire credit to our team members for their dedication and commitment to understand the niche Regulatory requirements and provide timely support and accurate advice to the customer, said Vardhini S Kirthivas Vice President, Medical Devices at Freyr
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam